glp 1 blindness study Links GLP-1 Drugs to Lower Risk of Legal in Patients with Type 2 Diabetes GLP-1 Receptor Agonists and vision

So whether they are safe, effective, or contain the stated amount of active ingredient is unclear

Some research suggests that chronic hyperglycaemia and insulin resistance may influence neurodegeneration, whilst other studies have noted that certain diabetes medications might modify Parkinson's risk

Evidence suggests that the deubiquitinase OTUB1, usually overexpressed in cancers, replicates the ferroptosis process and promotes tumor development by stabilizing the cystine transporter SLC7A11 (Gan, 2019)

Bottom line: Route of administration and regulatory status matter here more than usualand most online discussions gloss over both

Ready to get started on your journey to a healthier you

2 This study found that GLP-1 receptor agonist use conferred a lower risk of nonexudative AMD compared to insulin after adjusting for follow-up duration using data from an ophthalmic center